Pakistan Ignores India's Request to Sent Back IAF Pilot Abhinandan by Air: Report

Agencies

March 1, 2019

New Delhi, Mar 1: Hours after Pakistan announced its decision to release Indian Air Force pilot Abhinandan Varthaman, India conveyed to Islamabad that it wants him to be sent back via aerial route and not through the Wagah land border, official sources said.

However, late in the night, Pakistan communicated to India that he will be returned through the Attari-Wagah border.

The Indian defence establishment was also mulling over sending a special aircraft to Pakistan to bring back Wing Commander Varthaman who was captured by Pakistan during an aerial combat on Wednesday.

Varthaman will now return home through the Wagah border which is around 25 km from Lahore in Pakistan.

The IAF pilot's MiG 21 was shot and he bailed out after bringing down one Pakistani F-16 fighter during a dogfight to repel a Pakistani attack on Wednesday morning.

Pakistan Prime Minister Imran Khan Thursday announced that Varthaman will be released on Friday as "peace gesture".

Tensions between India and Pakistan escalated after Indian fighters bombed terror group Jaish-e-Mohammed's biggest training camp near Balakot deep inside Pakistan early Tuesday.

It came 12 days after 40 CRPF personnel were killed when a Jaish-e-Mohammad suicide bomber rammed a vehicle carrying over 100 kg of explosives into their bus in Pulwama district of Jammu and Kashmir on February 14.

Following the bombing of the JeM training camp, the Pakistan Air Force carried out a retaliatory aerial combat, unsuccessfully targeting several Indian military installations.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments